Article Details
Retrieved on: 2022-07-14 23:58:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... of neutralizing monoclonal antibodies (casirivimab and imdevimab) in patients with non-severe COVID-19, at the highest risk of severe disease, ...
Article found on: reliefweb.int
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here